doxapram has been researched along with Arterial Obstructive Diseases in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
| Excerpt | Relevance | Reference |
|---|---|---|
| "of doxapram." | 1.31 | Doxapram accentuates white matter injury in neonatal rats following bilateral carotid artery occlusion. ( Hasegawa, K; Nagai, H; Naito, T; Ochiai, R; Sawada, T; Uehara, H; Yoshioka, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uehara, H | 1 |
| Yoshioka, H | 1 |
| Nagai, H | 1 |
| Ochiai, R | 1 |
| Naito, T | 1 |
| Hasegawa, K | 1 |
| Sawada, T | 1 |
1 other study available for doxapram and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Doxapram accentuates white matter injury in neonatal rats following bilateral carotid artery occlusion.
Topics: Animals; Animals, Newborn; Arterial Occlusive Diseases; Brain; Carotid Arteries; Doxapram; Humans; I | 2000 |